Patent intelligence · US
US 9637597
DOPA-melanin formation in high ionic strength solutions
DOPA-melanin formation in high ionic strength solutions
Patent details — US 9637597
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 2, 2017
- Expiration
- Apr 27, 2037
- Applicant
- Northwestern University
- Claims
- 31
- CPC classes
- A61K, A61K9/0024, A61K9/1641, A61P
Quick answer
US 9637597 (DOPA-melanin formation in high ionic strength solutions) is held by Northwestern University. Status: granted. Granted May 2, 2017. Expires Apr 27, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Northwestern University
- Grant date
- Expiration
- Claims
- 31
- CPC classes
- A61K, A61K9/0024, A61K9/1641, A61P, A61P31/04
More from Northwestern University
Related pharmaceutical patents in our USPTO index.
-
US 12421280
Insulin like growth factor binding protein bioactive peptide fragments
granted -
US 12414995
Bifunctional compounds comprising Apcin-A and their use in the treatment of cancer
granted -
US 12414981
JNK inhibitors for use in treating and preventing neurodegenerative disorders
granted -
US 12414963
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 12415995
Bacterial toxins and uses thereof as Ras specific proteases for treating cell proliferation diseases and disorders
granted -
US 12409205
Nanomolecules for the treatment of inflammatory bowel diseases
granted -
US 12410474
Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patient
granted -
US 12404533
Bioconjugate vaccines' synthesis in prokaryotic cell lysates
granted
Related coverage
BBSW AI Solution: Key Insights from the 2026 Event
The BBSW AI Solution event in Foster, USA, promises to unveil critical advancements in AI technology for the pharma industry. Stay tuned for live updates and key takeaways.
BBSW AI Solution 2026: Key Insights and Highlights
The BBSW AI Solution event in 2026 is set to unveil groundbreaking advancements in AI technology. Join us for live coverage and key insights from industry leaders.
Frequently asked questions
What is US patent 9637597?
US 9637597 (DOPA-melanin formation in high ionic strength solutions) is held by Northwestern University. Status: granted. Granted May 2, 2017. Expires Apr 27, 2037 (11 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9637597?
Northwestern University is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 595 pharmaceutical patents for this assignee.
When does US 9637597 expire?
Our index shows an expiration date of Apr 27, 2037 (11 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.